Clear dose-response from 0.3 mg to 4.5 mg
After having a B12 shot, a person should monitor for adverse symptoms and seek medical help if they experience: severe pain at the injection site mild diarrhea a swelling sensation in the body temporary itching of the skin In rare cases, a person may also be at risk of: pulmonary edema peripheral vascular thrombosis, which involves blood clots polycythemia vera, which is a type of blood cancer If anyone experiences difficulty breathing, hives, and swelling, they need emergency medical help
ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
99% purity, HPLC-tested, COA
96 participants were randomly assigned to groups of 6 multiple-ascending doses of once-weekly subcutaneous cagrilintide (final doses of 0.16, 0.30, 0.60, 1.2, 2.4, and 4.5 mg) in combination with once-weekly subcutaneous semaglutide 2.4 mg or semaglutide 2.4 mg with placebo for 20 weeks